Literature DB >> 26250931

[Long QT syndrome. History, genetics, clinical symptoms, causes and therapy].

T Krönauer1, P Friederich.   

Abstract

The long QT syndrome is caused by a change in cardiac repolarization due to functional ion channel defects. A differentiation is made between a congenital (cLQTS) and an acquired (aLQTS) form of the disease. The disease results in the name-giving prolongation of the QT interval in the electrocardiogram and represents a predisposition for cardiac arrhythmia and sudden cardiac death. This article summarizes the current knowledge on the history, pathophysiology, clinical symptoms and therapy of cLQTS and aLQTS. This knowledge of pathophysiological features of the symptoms allows the underlying anesthesiological approach for individualized perioperative concepts for patients suffering from LQTS to be derived.

Entities:  

Mesh:

Year:  2015        PMID: 26250931     DOI: 10.1007/s00101-015-0068-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  48 in total

Review 1.  Molecular and cellular mechanisms of cardiac arrhythmias.

Authors:  M T Keating; M C Sanguinetti
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.

Authors:  M C Sanguinetti; M E Curran; A Zou; J Shen; P S Spector; D L Atkinson; M T Keating
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

3.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

4.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

Authors:  David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

5.  Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Authors:  Ping Yang; Hideaki Kanki; Benoit Drolet; Tao Yang; Jian Wei; Prakash C Viswanathan; Stefan H Hohnloser; Wataru Shimizu; Peter J Schwartz; Marshall Stanton; Katherine T Murray; Kris Norris; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

Review 6.  [Long QT syndrome and Brugada syndrome. Drugs, ablation or ICD?].

Authors:  Wilhelm Haverkamp; Sascha Rolf; Lars Eckardt; Gerold Mönnig
Journal:  Herz       Date:  2005-03       Impact factor: 1.443

7.  Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia.

Authors:  Peter Nagele; Swatilika Pal; Frank Brown; Jane Blood; J Philipp Miller; Joshua Johnston
Journal:  Anesthesiology       Date:  2012-08       Impact factor: 7.892

8.  The long QT syndrome: a prospective international study.

Authors:  A J Moss; P J Schwartz; R S Crampton; E Locati; E Carleen
Journal:  Circulation       Date:  1985-01       Impact factor: 29.690

9.  Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability.

Authors:  C M Pratt; S Ruberg; J Morganroth; B McNutt; J Woodward; S Harris; J Ruskin; L Moye
Journal:  Am Heart J       Date:  1996-03       Impact factor: 4.749

10.  Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry.

Authors:  E H Locati; W Zareba; A J Moss; P J Schwartz; G M Vincent; M H Lehmann; J A Towbin; S G Priori; C Napolitano; J L Robinson; M Andrews; K Timothy; W J Hall
Journal:  Circulation       Date:  1998-06-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.